| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
2.98 -0.08 (-0.03%) |
12-14 15:28 |
|
Open: |
3.03 |
Pre close: |
3.06 |
Target:
|
4.32 
|
|
High: |
3.08 |
Low: |
2.91 |
Resistance:
|
3.69
4.18
|
|
Volume: |
232,022 |
Market Cap: |
85M |
Support:
|
2.91
2.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.17
|
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
3.34 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
3.71 |
Stochastic Oscillator |
%K(14,3):
|
17.72 |
|
MA(250): |
3.71  |
%D(3): |
26.26 |
|
Average Volume(K) |
3-Month: |
46582
|
52-Week |
High:
|
5.83 |
|
10-Days: |
25740 |
Low: |
1.74 |
|
RSI |
RSI(14):
|
34.38 |
Change(%): |
65.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.680 |
Return on Equity (ttm) |
-177.8 |
Shares Out. (M) |
28.50 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-52.3 |
Shares Float (M) |
27.78 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.50 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
26.4 |
% Held by Institutions |
85.80 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.200 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.35 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.70 |
|
Profit Margin |
-74.95 |
Operating Cash Flow
(M) |
-13.42 |
P/S |
91695648.00 |
|
Operating Margin |
-72.77 |
Levered Free Cash Flow
(M) |
-8.90 |
P/CF |
-6.29 |
|
|
|
|
|
|
